Craig Doig

1.4k citations
32 papers · 704 indexed · h-index 16
Topics
Hormonal Regulation and Hypertension (12 papers)PARP inhibition in cancer therapy (8 papers)Adipose Tissue and Metabolism (7 papers)

In The Last Decade

Craig Doig

29 papers receiving 696 citations

Peers

Craig Doig
Comparison fields: 5 of 82
  • Molecular Biology 269
  • Endocrinology, Diabetes and Metabolism 202
  • Physiology 156
  • Oncology 105
  • Epidemiology 105
Replace Daniela Fliegner with:
Daniela Fliegner Germany
Michael N. Davies United States
Stefanie Petzold Germany
Shu Zhuo China
Ruochuan Cheng China
Shengkai Zuo China
Jiaxin Li China
Chakradhar Velagapudi United States
Ji Ho Suh United States
Craig Doig relative to Daniela Fliegner Germany Daniela Fliegner's profile →
Citations per field
00.5×1.5×2.2×
Daniela Fliegner · 1×
Citations per year

Countries citing papers authored by Craig Doig

Since Specialization
Citations

This map shows the geographic impact of Craig Doig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Doig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Doig more than expected).

Fields of papers citing papers by Craig Doig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Doig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Doig. The network helps show where Craig Doig may publish in the future.

Co-authorship network of co-authors of Craig Doig

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Doig. A scholar is included among the top collaborators of Craig Doig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Doig. Craig Doig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 5
4 1
5 0
6 3
7 24
8 15
9 14
10 7
11 32
12 6
13 90
14 4
15 16
16 5
17 13
18 91
19 55
20 49

About Craig Doig

Craig Doig is a scholar working on Geriatrics and Gerontology, Endocrinology, Diabetes and Metabolism and Behavioral Neuroscience, having authored 32 papers that have together received 704 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (12 papers), PARP inhibition in cancer therapy (8 papers) and Adipose Tissue and Metabolism (7 papers). The work is most often cited by research in Geriatrics and Gerontology (90 citations), Physiology (56 citations) and Endocrinology, Diabetes and Metabolism (202 citations). Craig Doig has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Gareth G. Lavery, Paul M. Stewart, Moray J. Campbell, Sebastiano Battaglia, Christopher J. McCabe, Jeremy Tomlinson, Stuart Morgan, Rachel S. Fletcher, Orla Maguire and Bryan M. Turner. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026